1. Mitral valve replacement with the glutaraldehyde-preserved porcine heterograft
- Author
-
Thomas J. Fogarty, Daniel J. Goodman, Donald C. Harrison, and Michael S. Horowitz
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,medicine.medical_treatment ,Mitral valve replacement ,Pannus ,Stent ,Atrial fibrillation ,medicine.disease ,Surgery ,Transplantation ,medicine.anatomical_structure ,Angiography ,medicine ,Cardiology and Cardiovascular Medicine ,business ,Cardiac catheterization ,Artery - Abstract
Follow-up studies were performed on the first 32 patients to undergo mitral valve replacement with the glutaraldehyde-preserved porcine heterograft premounted on a semirigid stent at the Stanford Medical Center. There was one operative death among the 23 patients who had isolated mitral valve replacement and two operative deaths among the remaining 9 patients who had additional valve surgery or coronary artery grafting. During the follow-up period of 483 months, or 17 ± 5 months per patient, there were three late deaths, two thromboembolic events within the first postoperative month in patients in atrial fibrillation, and one reoperation. A pannus of tissue formed on the atrial side of an otherwise normal heterograft necessitated the one reoperation because of inflow obstruction. Functional improvement from preoperative Class III or IV to postoperative Class I or II was noted in 24 of the 29 survivors of the operation, an 83 per cent improvement rate. Catheterization in the 5 unimproved patients, performed 6 ± 3 months after operation, showed advanced left ventricular disease and normal heterograft function in 4 and mitral restenosis in the fifth. Catheterization in 5 clinically improved patients 17 ± 4 months after operation showed normal heterograft and normal regurgitation. The mean gradient across the ten mitral heterografts averaged 5.7 ± 2 mm. Hg. ventricular function. Angiography in these 10 patients showed no significant mitral Normal heterograft histology was noted in four recovered valves at 4, 4, 18, and 29 months.
- Published
- 1974